Esophageal Adenocarcinoma

general

A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus. Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported. Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas. Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. The prognosis is poor.

80

Centers

186

Active Trials

$2.2B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Esophageal Adenocarcinoma(80)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.1
2
NCI Comprehensive
High-Volume Research Center
83.9
3
NCI Comprehensive
High-Volume Research Center
82.3
4
NCI Comprehensive
High-Volume Research Center
78.2
5
High-Volume Research Center
76.1
6
NCI Comprehensive
High-Volume Research Center
74.0
7
NCI Comprehensive
High-Volume Research Center
72.0
8
NCI Comprehensive
High-Volume Research Center
70.4
9
Active Research Program
68.9
10
NCI Comprehensive
Active Research Program
67.4
11
Active Research Program
64.6
12
Active Research Program
64.6
13
NCI Comprehensive
Active Research Program
63.7
14
Active Research Program
62.9
15
NCI Comprehensive
Active Research Program
61.2
16
NCI Comprehensive
Active Research Program
60.9
17
NCI Comprehensive
Active Research Program
60.9
18
NCI Comprehensive
Active Research Program
60.9
19
NCI Comprehensive
Active Research Program
56.3
20
NCI Comprehensive
Active Research Program
56.3
21
NCI Comprehensive
Active Research Program
56.3
22
NCI Comprehensive
Active Research Program
56.3
23
Active Research Program
56.3
24
Active Research Program
56.3
25
NCI Comprehensive
Active Research Program
55.1
26
NCI Clinical
Active Research Program
53.5
27
NCI Comprehensive
Active Research Program
52.0
28
NCI Comprehensive
Active Research Program
51.0
29
NCI Comprehensive
Active Research Program
49.9
30
NCI Comprehensive
Active Research Program
49.4
31
NCI Clinical
Active Research Program
48.4
32
NCI Comprehensive
Active Research Program
47.4
33
NCI Comprehensive
Active Research Program
47.0
34
NCI Comprehensive
Active Research Program
47.0
35
NCI Comprehensive
Active Research Program
47.0
36
NCI Comprehensive
Active Research Program
47.0
37
NCI Comprehensive
Active Research Program
47.0
38
NCI Comprehensive
Active Research Program
47.0
39
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
47.0
40
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.0
41
NCI Comprehensive
Active Research Program
47.0
42
NCI Comprehensive
Active Research Program
47.0
4347.0
44
Active Research Program
47.0
45
Active Research Program
47.0
46
Active Research Program
47.0
47
Active Research Program
47.0
48
NCI Comprehensive
Active Research Program
46.8
49
NCI Comprehensive
Active Research Program
46.3
50
NCI Comprehensive
Active Research Program
45.8
51
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
44.8
52
NCI Comprehensive
Active Research Program
44.3
53
Active Research Program
43.2
54
NCI Comprehensive
31.1
5531.1
56
NCI Comprehensive
31.1
57
NCI Comprehensive
31.1
58
NCI Comprehensive
31.1
59
NCI Comprehensive
31.1
60
NCI Comprehensive
31.1
6131.1
6231.1
6331.1
64
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
31.1
65
NCI Basic_laboratory
31.1
6631.1
6731.1
6831.1
69
70
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
71
NCI Clinical
72
73
74
NCI Comprehensive
75
76
77
78
79
80

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →